Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades' - Cleveland-Cliffs (NYSE:CLF), Bristol-Myers Squibb (NYSE:BMY)


On CNBC’s “Halftime Report Final Trades,” Cerity Partners’ Jim Lebenthal picked Cleveland-Cliffs Inc. (NYSE:CLF).

On Friday, Goldman Sachs analyst Mike Harris maintained a Buy score on Cleveland-Cliffs and raised the value goal from $14.5 to $16.

Don’t overlook to take a look at our premarket coverage here

Joshua Brown, CEO of Ritholtz Wealth Management, stated Rocket Companies, Inc. (NYSE:RKT) reported a great quarter.

Rocket Companies on Oct. 30 posted higher-than-anticipated third-quarter earnings. The firm reported quarterly earnings of seven cents per share, beating the Street estimate of 5 cents. Quarterly income clocked in at $1.78 billion, which beat the consensus estimate of $1.66 billion.

Kevin Simpson, CEO of Capital Wealth Planning, named Meta Platforms, Inc. (NASDAQ:META) as his last commerce.

Meta, on Oct. 29, reported quarterly diluted earnings per share of $1.05, which features a one-time, non-money revenue tax cost of $15.93 billion and should not examine to estimates of $6.68. On an adjusted foundation, earnings per share got here in at $7.25, in keeping with Benzinga Pro.

Gilman Hill Asset Management CEO Jenny Van Leeuwen Harrington named Bristol-Myers Squibb Company (NYSE:BMY) as her last commerce.

Bristol Myers Squibb, on Oct. 30, reported third-quarter 2025 revenues of $12.22 billion on Thursday, beating the consensus of $11.81 billion, a 3% enhance 12 months over 12 months.

Price Action:

  • Rocket shares gained 4.5% to shut at $16.66 on Friday.
  • Meta shares fell 2.7% to shut at $648.35 through the session.
  • Cleveland-Cliffs shares gained 1.4% to shut at $12.43 on Friday.
  • Bristol-Myers Squibb shares gained 1% to shut at $46.07.

Check This Out:

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs